Vaginal Dinoprostone Administration Prior to a T380A Intrauterine Device Insertion in Nulliparous Women.
Launched by CAIRO UNIVERSITY · Sep 25, 2018
Trial Information
Current as of May 09, 2025
Completed
Keywords
ClinConnect Summary
Women may experience pain and technical difficulties may be encountered when insertion of an intrauterine device (IUD) is attempted through a narrow cervical canal.IUD insertion- related complications and side effects are more common among women who had never delivered vaginally.n American College of Obstetricians and Gynecologists committee opinion encourages providers to use IUDs as a first line of contraception in nulliparous women.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Nulliparous women aged over 18 years of age requesting a copper IUD for contraception, had a negative pregnancy test.
- Exclusion Criteria:
- • • a prior pregnancy greater than 20 weeks of duration
- • currently pregnant or were pregnant within 6 weeks of study entry
- • had a prior attempted or successful IUD insertion
- • had a history of a cervical procedure such as cone biopsy, Loop electrosurgical excision procedure, or cryotherapy
- • any World Health Organization Medical Eligibility Criteria category 3 or 4 precaution to an IUD
- • active vaginitis or cervicitis
- • undiagnosed abnormal uterine bleeding
- • pelvic inflammatory disease within the last 3 months
- • fibroids or other uterine abnormalities distorting the uterine cavity
- • contraindication to dinoprostone.
About Cairo University
Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Giza, , Egypt
Patients applied
Trial Officials
AHMED SAMY, MD
Principal Investigator
Cairo University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials